Intra-arterial peptide-receptor radionuclide therapy for neuro-endocrine tumour liver metastases: an in-patient randomised controlled trial (LUTIA).
Ebbers SC, Barentsz MW, de Vries-Huizing DMV, Versleijen MWJ, Klompenhouwer EG, Tesselaar MET, Stokkel MPM, Brabander T, Hofland J, Moelker A, van Leeuwaarde RS, Smits MLJ, Braat AJAT, Lam MGEH.
Ebbers SC, et al. Among authors: braat ajat.
Eur J Nucl Med Mol Imaging. 2024 Mar;51(4):1121-1132. doi: 10.1007/s00259-023-06467-y. Epub 2023 Oct 28.
Eur J Nucl Med Mol Imaging. 2024.
PMID: 37897617
Free PMC article.
Clinical Trial.